BiotechTube

Foralumab TZLS-401 50 µg + Foralumab TZLS-401 100 µg

Phase 2Recruiting
0 views this week 0 watching💤 Quiet
Interest: 32/100
32
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Dementia

Conditions

Dementia, Alzheimers Disease, Mild Cognitive Impairment Due to Alzheimer's Disease

Trial Timeline

Sep 16, 2025 → Dec 1, 2026

NCT ID
NCT06489548

About Foralumab TZLS-401 50 µg + Foralumab TZLS-401 100 µg

Foralumab TZLS-401 50 µg + Foralumab TZLS-401 100 µg is a phase 2 stage product being developed by Tiziana Life Sciences for Dementia. The current trial status is recruiting. This product is registered under clinical trial identifier NCT06489548. Target conditions include Dementia, Alzheimers Disease, Mild Cognitive Impairment Due to Alzheimer's Disease.

What happened to similar drugs?

9 of 20 similar drugs in Dementia were approved

Approved (9) Terminated (1) Active (10)
✅E2020 + PlaceboEisaiApproved
✅donepezil hydrochloride (Aricept)EisaiApproved
✅MecobalaminEisaiApproved
✅Donepezil hydrochloride + Donepezil matching placebo + Donepezil hydrochlorideEisaiApproved
✅Risperdal,reminylJohnson & JohnsonApproved
✅ENA713NovartisApproved
✅Rivastigmine Patch 9.5 cm2NovartisApproved

Hype Score Breakdown

Clinical
12
Activity
15
Company
5
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT06489548Phase 2Recruiting

Competing Products

20 competing products in Dementia

See all competitors
ProductCompanyStageHype Score
[18F]NAV4694Navidea BiopharmaceuticalsPhase 3
26
AL001 + Placebo + Open label - AL001AlectorPhase 3
22
AL001AlectorPhase 2
25
ATH-1017 + PlaceboLeonaBioPhase 2
17
IGC AD1 + PlaceboIGC PharmaPhase 1
19
E2020 + PlaceboEisaiApproved
43
ARICEPTEisaiPhase 3
40
RasagilineEisaiPhase 2
35
Donepezil HydrochlorideEisaiPre-clinical
26
donepezil hclEisaiPhase 3
40
Donepezil 5 mg + Donepezil 10 mg + Donepezil matched placeboEisaiPhase 3
40
E2020 + E2020EisaiPhase 2
35
donepezil hydrochloride (Aricept)EisaiApproved
43
3 mg Donepezil hydrochloride + 5 mg Donepezil hydrochloride + 10 mg Donepezil hydrochloride + PlaceboEisaiPhase 2
35
E2020 + E2020EisaiPhase 3
40
Irsenontrine + PlaceboEisaiPhase 2
35
E2020EisaiPhase 2
35
MecobalaminEisaiApproved
43
E2020 + PlaceboEisaiPhase 3
40
Donepezil HydrochlorideEisaiPhase 3
40